UNSPSC 51384504: Carpofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H12CLNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FFL0D546HO. The term carpofen is a European Pharmacopoeia designation. SMILES: CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O.

UNSPSC 51384504 Carpofen, a Commodity code, nominally names a veterinary anti-inflammatory pharmaceutical, but recent state and local solicitations tagged under this code show no carpofen procurement activity. Instead, the recorded opportunities reflect purchases of human pharmaceuticals and related health systems — naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products. The mismatch between the code's nominal scope and the actual work being solicited suggests either systematic miscoding in the state and local procurement databases or that the code has been repurposed for broader pharmaceutical procurement. State and local issuing bodies pursuing pharmaceutical supply include county health departments, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions and member agencies. Procurement vehicles include competitive sealed bids (IFB), requests for information (RFI), and cooperative purchasing RFPs managed by multistate alliances.

Recent activity spans Florida, Texas, and Minnesota-led multistate purchasing. Seminole County, Florida issued IFB 60459723LAS in June 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling future formal solicitation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota Department of Administration's Office of State Procurement, released RFP S1070000015802 in January 2026 to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026 and effective award date July 1, 2026.